Daniel Bradbury - Sep 1, 2022 Form 4 Insider Report for CASTLE BIOSCIENCES INC (CSTL)

Role
Director
Signature
/s/ Greg Acosta, Attorney-in-fact
Stock symbol
CSTL
Transactions as of
Sep 1, 2022
Transactions value $
-$216,328
Form type
4
Date filed
9/6/2022, 04:48 PM
Previous filing
Aug 3, 2022
Next filing
Oct 5, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CSTL Common Stock Sale -$216K -7.7K -3.24% $28.08 230K Sep 1, 2022 By LLC F1, F2, F3
holding CSTL Common Stock 830 Sep 1, 2022 Direct
holding CSTL Common Stock 97.8K Sep 1, 2022 By Daniel Bradbury Irrecovable Descendant's Trust F4
holding CSTL Common Stock 97.8K Sep 1, 2022 By Annette Bradbury Irrecovable Descendant's Trust F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transaction on this Form 4 was made pursuant to a Rule 10b5-1 plan adopted by BioBrit, LLC on June 8, 2022.
F2 This transaction was executed in multiple trades at prices ranging from $27.52 to $28.42, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3 Held by BioBrit, LLC, of which the Reporting Person is the managing member and has voting and investment power over the shares.
F4 Held by Daniel Bradbury Irrecovable Descendant's Trust of which the reporting person and his spouse are trustees and their children are beneficiaries.
F5 Held by Annette Bradbury Irrecovable Descendant's Trust of which the reporting person and his spouse are trustees and their children are beneficiaries.